Aberrant methylation of GSTM1 has been found in various cancers, such as acute myeloid leukaemia, urothelial carcinoma and head and neck cancer (Sharma et al., 2010; Ohgami et al., 2012; Wang et al., 2016). Here, GSTM1 is linked to acute myeloid leukemia.